New program aims to protect liver patients from dangerous painkiller side effects during surgery

NCT ID NCT07249294

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a hospital program to avoid giving NSAIDs or metamizole to people with advanced chronic liver disease who need major surgery. These painkillers are risky for them because they can cause kidney damage, fluid buildup, or bleeding. The program will track how often these drugs are prescribed and whether it reduces complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PORTAL HYPERTENSION RELATED TO CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure portal hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital del Mar

    Barcelona, 08003, Spain